Interestingly, another series of recent experiments indicate that, apart from healing the heart, the activation of ErbB signaling with systemic NRG-1 may also mitigate common co-morbidities of heart failure, including diabetes, atherosclerosis, pulmonary hypertension, and renal dysfunction [12, 40, 56, 59]. Here, EGFR is linked to heart failure.